Kim Elaine Barrett

机构：University of California, Davis · ORCID：0000-0002-6704-998X

发表论文 461 篇 · 总被引 10670 次 · h-index 56

代表论文

• Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial (2023 · The Lancet Diabetes & Endocrinology · 被引 122)
• Intestinal secretory mechanisms and diarrhea (2022 · American Journal of Physiology-Gastrointestinal and Liver Physiology · 被引 99)
• A prebiotic fructo-oligosaccharide promotes tight junction assembly in intestinal epithelial cells via an AMPK-dependent pathway (2020 · Biomedicine & Pharmacotherapy · 被引 76)
• Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial (2025 · The Lancet · 被引 73)
• T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling (2021 · Journal of Clinical Investigation · 被引 46)
• Potentiation of calcium‐activated chloride secretion and barrier dysfunction may underlie EGF receptor tyrosine kinase inhibitor‐induced diarrhea (2020 · Physiological Reports · 被引 33)